Overall, these previously unreported clinical associations between Xi and Xa aberrations, cancer aggressiveness, and survival outcome offer new insight into the understudied complexities of the X chromosome in breast cancer and links to TP53 alterations. This evidence concerns the gene TP53 and breast cancer.